Literature DB >> 3800657

Studies on the mechanism of entry of vaccinia virus in animal cells.

R A Janeczko, J F Rodriguez, M Esteban.   

Abstract

In order to study the mechanism of entry of vaccinia virus into cells the fate of virion associated polypeptides was investigated during infection of african green monkey kidney (BSC-40) cells with 35 S-methionine labelled virus. Approximately 12-15 percent of the virion polypeptides were degraded to acid-soluble products by 3 hours post-infection. Proteolysis was inhibited (50 percent) by methylamine, suggesting a lysosomal site of degradation. Neither methylamine or chloroquine inhibited virus infectivity or uncoating indicating a non-acid endocytic mechanism of entry. Subcellular fractionation studies on density gradients indicated that the bulk of the input virion polypeptides were associated with the plasma membrane fraction. In addition, input virion DNA was partially resolved from the membrane fraction. The results are most consistent with a mechanism of entry involving fusion of the virus with the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3800657     DOI: 10.1007/bf01310068

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  21 in total

1.  The purification fo four strains of poxvirus.

Authors:  W K JOKLIK
Journal:  Virology       Date:  1962-09       Impact factor: 3.616

2.  Biogenesis of vaccinia: isolation and characterization of a surface component that elicits antibody suppressing infectivity and cell-cell fusion.

Authors:  W Stern; S Dales
Journal:  Virology       Date:  1976-11       Impact factor: 3.616

3.  Inhibitors of lysosomal function.

Authors:  P O Seglen
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

Review 4.  Perturbation of vesicular traffic with the carboxylic ionophore monensin.

Authors:  A M Tartakoff
Journal:  Cell       Date:  1983-04       Impact factor: 41.582

Review 5.  Membrane fusion proteins of enveloped animal viruses.

Authors:  J White; M Kielian; A Helenius
Journal:  Q Rev Biophys       Date:  1983-05       Impact factor: 5.318

6.  Uncoating of vaccinia virus.

Authors:  V Zaslavsky
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

7.  Adsorption and penetration of the trypsinized vaccinia virion.

Authors:  Y Ichihashi; M Oie
Journal:  Virology       Date:  1980-02       Impact factor: 3.616

8.  Inhibition of Semliki forest virus penetration by lysosomotropic weak bases.

Authors:  A Helenius; M Marsh; J White
Journal:  J Gen Virol       Date:  1982-01       Impact factor: 3.891

9.  Insertion of biologically active membrane proteins from rat liver into the plasma membrane of mouse fibroblasts.

Authors:  H Baumann; E Hou; D Doyle
Journal:  J Biol Chem       Date:  1980-10-25       Impact factor: 5.157

10.  The role of intermediate vesicles in the adsorptive endocytosis and transport of ligand to lysosomes by human fibroblasts.

Authors:  M Merion; W S Sly
Journal:  J Cell Biol       Date:  1983-03       Impact factor: 10.539

View more
  20 in total

1.  Vaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related L1 protein.

Authors:  Erica Brown; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway.

Authors:  Alan C Townsley; Andrea S Weisberg; Timothy R Wagenaar; Bernard Moss
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  Cryo-electron tomography of vaccinia virus.

Authors:  Marek Cyrklaff; Cristina Risco; Jose Jesús Fernández; Maria Victoria Jiménez; Mariano Estéban; Wolfgang Baumeister; José L Carrascosa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

4.  Entry of vaccinia virus and cell-cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L gene.

Authors:  Suany Ojeda; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  The product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion.

Authors:  Alan C Townsley; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane.

Authors:  R W Doms; R Blumenthal; B Moss
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

7.  Structural and biochemical characterization of the vaccinia virus envelope protein D8 and its recognition by the antibody LA5.

Authors:  Michael H Matho; Matt Maybeno; Mohammed Rafii-El-Idrissi Benhnia; Danielle Becker; Xiangzhi Meng; Yan Xiang; Shane Crotty; Bjoern Peters; Dirk M Zajonc
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

8.  Vaccinia virus A21 virion membrane protein is required for cell entry and fusion.

Authors:  Alan C Townsley; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

9.  Vaccinia virus H2 protein is an essential component of a complex involved in virus entry and cell-cell fusion.

Authors:  Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

10.  Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.

Authors:  S E Altmann; J C Jones; S Schultz-Cherry; C R Brandt
Journal:  Virology       Date:  2009-04-22       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.